Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other antineoplastic agents

Ogsiveo

(nirogacestat)

Uses, side effects, dosage information & price range

Merck Europe B.V.

About this medicine

Ogsiveo as monotherapy is indicated for the treatment of adult patients with progressing desmoid tumours who require systemic treatment.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

Bortezomib HospiraComposition: bortezomibPfizer Europe MA EEIG

Price on RequestView Details →

Topotecan HospiraComposition: topotecanPfizer Europe MA EEIG

Price on RequestView Details →

KrazatiComposition: adagrasibBristol-Myers Squibb Pharma EEIG

Price on RequestView Details →

KymriahComposition: tisagenlecleucelNovartis Europharm Limited

Price on RequestView Details →

KinselbyComposition: resminostat4Sc AG

Price on RequestView Details →

Key Information

Salt / Composition

nirogacestat

Category

Other antineoplastic agents

Manufacturer

Merck Europe B.V.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.